Redefining Endometriosis Care: Earlier Diagnosis and Medical Management in Practice

Endometriosis affects far more women than commonly cited figures suggest, and the gap between perception and reality shapes how the disease is diagnosed and treated.

Identifying who is most at risk for endometriosis, and recognizing its hallmark symptoms early, can shorten the path to diagnosis and reduce its enormous economic toll.

In "Why Endometriosis Diagnosis Is Often Delayed by a Decade," the panel unpacks the factors behind a diagnostic delay that can stretch a decade.

In "ACOG's New Guidance on Diagnosing Endometriosis Without Surgery," Dr. Davitt reflects on what ACOG's March 2026 guideline update means in daily practice.

In "Understanding the Different Types of Endometriosis Lesions," our experts turn to the primary goals of treatment and the disease's four distinct subtypes.

"Weighing Surgical Versus Medical Management in Endometriosis" takes up the question of when a patient's endometriosis care should shift from medicine to the operating room.

In "Why Estrogen Suppression Anchors Endometriosis Treatment," the panel explores the biological rationale that makes estrogen suppression the backbone of medical therapy.

In "Comparing GnRH Agonists and Antagonists for Endometriosis Pain," Dr. Davitt explains the mechanistic split between two major drug classes used to manage endometriosis pain.

In "Choosing Between Newer GnRH Antagonist Therapies for Endometriosis," Dr. Davitt compares two newer, FDA-approved options for treating endometriosis-associated pain.

In "Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain," the panel reviews two-year outcomes from a major open-label extension trial.

This episode, "Add-Back Therapy: Balancing Efficacy and Safety in Endometriosis," features Dr. Davitt reviewing 12-month efficacy and safety data on add-back therapy.

In "Monitoring Safety and Symptom Relief During Endometriosis Therapy," Dr. Davitt details the practical monitoring plan he follows once a patient begins therapy.

In "Improving Shared Decision-Making in Endometriosis Care," the panel opens Section 3 by asking why medical management still lags in everyday practice.